M. Zanini

872 total citations
24 papers, 654 citations indexed

About

M. Zanini is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, M. Zanini has authored 24 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 14 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in M. Zanini's work include Lymphoma Diagnosis and Treatment (14 papers), Lung Cancer Treatments and Mutations (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). M. Zanini is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Lung Cancer Treatments and Mutations (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). M. Zanini collaborates with scholars based in Italy and United States. M. Zanini's co-authors include Pinuccia Valagussa, Simonetta Viviani, Gianni Bonadonna, Armando Santoro, V. Bonfante, Liliana Devizzi, F. Soncini, Monica Balzarotti, Carlo Tondini and Roberto Giardini and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

M. Zanini

22 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Zanini Italy 14 479 307 222 209 114 24 654
Luca Nassi Italy 13 516 1.1× 193 0.6× 170 0.8× 211 1.0× 83 0.7× 39 675
M. Hoffmann Austria 12 518 1.1× 214 0.7× 159 0.7× 112 0.5× 136 1.2× 20 674
M. Crump Canada 9 187 0.4× 177 0.6× 121 0.5× 121 0.6× 48 0.4× 20 462
Chung K.K. Lee United States 13 263 0.5× 113 0.4× 197 0.9× 96 0.5× 64 0.6× 20 519
José C. Díaz‐Maqueo Mexico 12 261 0.5× 294 1.0× 52 0.2× 89 0.4× 72 0.6× 34 529
Caroline Kuhlman United States 8 338 0.7× 301 1.0× 56 0.3× 65 0.3× 130 1.1× 12 596
Julye C. Lavoie Canada 16 326 0.7× 304 1.0× 70 0.3× 101 0.5× 227 2.0× 35 740
Carmen Ruiz de Elvira France 9 430 0.9× 427 1.4× 85 0.4× 61 0.3× 200 1.8× 13 812
Menachem Ben-Shahar Israel 14 307 0.6× 262 0.9× 138 0.6× 155 0.7× 81 0.7× 24 802
Luciano Guardigni Italy 7 457 1.0× 361 1.2× 68 0.3× 152 0.7× 145 1.3× 11 560

Countries citing papers authored by M. Zanini

Since Specialization
Citations

This map shows the geographic impact of M. Zanini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Zanini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Zanini more than expected).

Fields of papers citing papers by M. Zanini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Zanini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Zanini. The network helps show where M. Zanini may publish in the future.

Co-authorship network of co-authors of M. Zanini

This figure shows the co-authorship network connecting the top 25 collaborators of M. Zanini. A scholar is included among the top collaborators of M. Zanini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Zanini. M. Zanini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ponzetti, Agostino, Rosella Spadi, Laura Fanchini, et al.. (2015). Jaw Osteonecrosis associated with Aflibercept, Irinotecan and Fluorouracil: Attention to Oral District. Tumori Journal. 102(2_suppl). S74–S77. 26 indexed citations
3.
Scozzari, Gitana, M. Zanini, Francesca Cravero, et al.. (2014). High incidence of trocar site hernia after laparoscopic or robotic Roux-en-Y gastric bypass. Surgical Endoscopy. 28(10). 2890–2898. 30 indexed citations
4.
Ponzetti, Agostino, Rosella Spadi, Laura Fanchini, et al.. (2013). Pilot Clinical Trial on the Efficacy of Prophylactic Use of Vitamin K1–Based Cream (Vigorskin) to Prevent Cetuximab-Induced Skin Rash in Patients With Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 13(1). 62–67. 29 indexed citations
5.
Santoro, Armando, Monica Balzarotti, Carlo Tondini, et al.. (1999). Dose-escalation of CHOP in non-Hodgkin's lymphoma. Annals of Oncology. 10(5). 519–526. 27 indexed citations
6.
Villani, Flavio, V. Bonfante, Simonetta Viviani, et al.. (1998). Late pulmonary toxicity after treatment for Hodgkin's disease.. PubMed. 17(6D). 4739–42. 22 indexed citations
7.
Tondini, Carlo, Monica Balzarotti, Armando Santoro, et al.. (1997). Initial chemotherapy for primary resectable large-cell lymphoma of the stomach. Annals of Oncology. 8(5). 497–499. 31 indexed citations
8.
Santoro, Armando, V. Bonfante, Simonetta Viviani, et al.. (1997). Four cycles of ABVD followed by involved field irradiation (IF-RT) is the treatment of choice for early-stage Hodgkin's disease (HD): 5-year results of a randomized trial. European Journal of Cancer. 33. S262–S262. 1 indexed citations
9.
Bonfante, V., Armando Santoro, Simonetta Viviani, et al.. (1997). Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.. Journal of Clinical Oncology. 15(2). 528–534. 132 indexed citations
10.
Viviani, Simonetta, V. Bonfante, M. Zanini, et al.. (1996). Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.. Journal of Clinical Oncology. 14(5). 1421–1430. 125 indexed citations
11.
Zanini, M., Simonetta Viviani, Armando Santoro, et al.. (1994). Extended-field radiotherapy in favorable stage IA–IIA Hodgkin's disease (Prognostic role of stage). International Journal of Radiation Oncology*Biology*Physics. 30(4). 813–819. 6 indexed citations
12.
Bonfante, V., Armando Santoro, Simonetta Viviani, et al.. (1993). Early stage Hodgkin's disease: Ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP. European Journal of Cancer. 29(1). 24–29. 16 indexed citations
13.
Tondini, Carlo, M. Zanini, Francesco Lombardi, et al.. (1993). Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas.. Journal of Clinical Oncology. 11(4). 720–725. 93 indexed citations
14.
Viviani, Simonetta, Gianni Bonadonna, Armando Santoro, et al.. (1991). Alternating versus hybrid MOPP-ABVD in Hodgkin’s disease: The Milan experience. Annals of Oncology. 2 Suppl 2. 55–62. 29 indexed citations
15.
Sheiban, Imad, G. P. Trevi, D Casarotto, et al.. (1988). Direct visualization of aorto-coronary bypass grafts by two-dimensional echocardiography: A new clinical application. CardioVascular and Interventional Radiology. 11(1). 14–17.
16.
Zanini, M., et al.. (1984). [Delayed myelitis caused by radiation in patients treated for Hodgkin's disease].. PubMed. 75(44). 2679–82. 2 indexed citations
17.
Zucali, R, M. Zanini, & Alberto Banfi. (1984). Significance of mediastinal involvement in early Hodgkin's disease. Hematological Oncology. 2(1). 72–74. 2 indexed citations
18.
Zanini, M., R Zucali, & Alberto Banfi. (1983). Bone and Soft Tissue Sarcomas in the Follow-Up of Hodgkin's Disease. Tumori Journal. 69(5). 473–476. 4 indexed citations
19.
Zucali, R, A Pagnoni, M. Zanini, Armando Santoro, & C Uslenghi. (1981). Radiological and spirometric evaluation of mediastinal and pulmonary late effects after radiotherapy and chemotherapy for Hodgkin's disease. 2(3). 169–176. 9 indexed citations
20.
Musumeci, R, et al.. (1977). Lymphographic Evaluation in Bone and Soft Tissue Sarcomas. Tumori Journal. 63(3). 283–288. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026